Scientists Create Blood Vessels, Capillaries for Lab-Grown Tissues
|
By LabMedica International staff writers Posted on 07 Feb 2011 |
Researchers have overcome one of the major hurdles on the path to growing transplantable tissue in the lab: they have found a way to grow the blood vessels and capillaries needed to keep tissues alive.
The new research, conducted by investigators from Rice University (Houston, TX, USA) and Baylor College of Medicine (BCM; Houston, TX, USA), is available online, and it was published in the January 2011 issue of the journal Acta Biomaterialia. "The inability to grow blood-vessel network --or vasculature--in lab-grown tissues is the leading problem in regenerative medicine today,” said lead coauthor Dr. Jennifer West, department chair, and professor of bioengineering at Rice. "If you don't have blood supply, you cannot make a tissue structure that is thicker than a couple hundred microns.”
As its base material, a team of researchers led by Dr. West and BCM molecular physiologist Dr. Mary Dickinson chose polyethylene glycol (PEG), a nontoxic plastic that is widely used in medical devices and food. Building on 10 years of research in Dr. West's lab, the scientists modified the PEG to mimic the body's extracellular matrix--the network of proteins and polysaccharides that comprise a considerable portion of most tissues.
Drs. West, Dickinson, Rice graduate student Jennifer Saik, Rice, undergraduate Emily Watkins, and Rice-BCM graduate student Daniel Gould combined the modified PEG with two kinds of cells--both of which are needed for blood-vessel formation. Using light that locks the PEG polymer strands into a solid gel, they created soft hydrogels that contained living cells and growth factors. After that, they filmed the hydrogels for 72 hours. By tagging each type of cell with a different colored fluorescent marker, the scientists were able to see as the cells gradually formed capillaries throughout the soft, plastic gel.
To assess these new vascular networks, the researchers implanted the hydrogels into the corneas of mice, where no natural vasculature exists. After injecting a dye into the mice's bloodstream, the researchers confirmed normal blood flow in the newly grown capillaries.
Another major development, conducted by Dr. West and graduate student Joseph Hoffmann, in November 2010, involved the generation of a new technique called two-photon lithography, an ultrasensitive method of using light to create intricate three-dimensional (3D) patterns within the soft PEG hydrogels. West said the patterning technique allows the engineers to exert a fine level of control over where cells move and grow. In follow-up research, also in collaboration with the Dickinson lab at BCM, Dr. West and her colleagues plan to use the technique to grow blood vessels in predetermined patterns.
Related Links:
Rice University
Baylor College of Medicine
The new research, conducted by investigators from Rice University (Houston, TX, USA) and Baylor College of Medicine (BCM; Houston, TX, USA), is available online, and it was published in the January 2011 issue of the journal Acta Biomaterialia. "The inability to grow blood-vessel network --or vasculature--in lab-grown tissues is the leading problem in regenerative medicine today,” said lead coauthor Dr. Jennifer West, department chair, and professor of bioengineering at Rice. "If you don't have blood supply, you cannot make a tissue structure that is thicker than a couple hundred microns.”
As its base material, a team of researchers led by Dr. West and BCM molecular physiologist Dr. Mary Dickinson chose polyethylene glycol (PEG), a nontoxic plastic that is widely used in medical devices and food. Building on 10 years of research in Dr. West's lab, the scientists modified the PEG to mimic the body's extracellular matrix--the network of proteins and polysaccharides that comprise a considerable portion of most tissues.
Drs. West, Dickinson, Rice graduate student Jennifer Saik, Rice, undergraduate Emily Watkins, and Rice-BCM graduate student Daniel Gould combined the modified PEG with two kinds of cells--both of which are needed for blood-vessel formation. Using light that locks the PEG polymer strands into a solid gel, they created soft hydrogels that contained living cells and growth factors. After that, they filmed the hydrogels for 72 hours. By tagging each type of cell with a different colored fluorescent marker, the scientists were able to see as the cells gradually formed capillaries throughout the soft, plastic gel.
To assess these new vascular networks, the researchers implanted the hydrogels into the corneas of mice, where no natural vasculature exists. After injecting a dye into the mice's bloodstream, the researchers confirmed normal blood flow in the newly grown capillaries.
Another major development, conducted by Dr. West and graduate student Joseph Hoffmann, in November 2010, involved the generation of a new technique called two-photon lithography, an ultrasensitive method of using light to create intricate three-dimensional (3D) patterns within the soft PEG hydrogels. West said the patterning technique allows the engineers to exert a fine level of control over where cells move and grow. In follow-up research, also in collaboration with the Dickinson lab at BCM, Dr. West and her colleagues plan to use the technique to grow blood vessels in predetermined patterns.
Related Links:
Rice University
Baylor College of Medicine
Latest BioResearch News
- Large-Scale Study Maps DNA Damage Signatures Across Multiple Cancers
- Study Identifies Distinct Immune Signatures to Early Depression and Psychosis
- Genetic Mutation Behind Aggressive Adult Leukemia Offers Treatment Clues
- Disease Gene Discovery Advances Diagnosis of Rare Movement Disorders
- Genetic Discovery Could Improve Diagnosis of Drug-Resistant Epilepsy
- Genetic Discovery May Improve Diagnosis of Rare Dementia Subtype
- Mass Spectrometry Technique Detects Protein and Sugar Changes in Neurodegeneration
- Barcoded DNA Sheds Light on Hidden Complexities in Breast Cancer Detection
- CRISPR-Based Platform Pinpoints Drivers of Acute Myeloid Leukemia in Patient Cells
- Protective Brain Protein Emerges as Biomarker Target in Alzheimer’s Disease
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
Channels
Clinical Chemistry
view channel
New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs
Steroid hormone measurement is a core application of clinical mass spectrometry, which is widely regarded as a diagnostic gold standard. Access to these high-specificity methods has often been constrained... Read more
Study Shows Dual Biomarkers Improve Accuracy of Alzheimer’s Detection
Alzheimer’s disease develops slowly, and biological changes can appear in blood many years before symptoms. While plasma assays for phosphorylated tau offer earlier detection, discerning whether these... Read moreMolecular Diagnostics
view channel
Plasma ctDNA Testing Predicts Breast Cancer Recurrence After Neoadjuvant Therapy
Accurate identification of breast cancer patients at risk of relapse after pre-surgery treatment is central to guiding adjuvant decisions, particularly in aggressive disease. Circulating fragments of tumor... Read more
New Respiratory Panel Expands Pathogen Detection to 25 Targets
Respiratory infections often present with overlapping symptoms, complicating differential diagnosis in acute and community settings. The stakes are higher for older adults, young children, and people with... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read more
Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
Early identification of treatment response and relapse remains a major challenge in solid tumors, where minimal residual disease is difficult to detect with routine imaging and blood tests.... Read moreMicrobiology
view channel
Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
Accurate and rapid identification of bacterial infections remains challenging in acute care, where delays can hinder timely, targeted therapy. Infectious diseases are a major cause of mortality worldwide,... Read more
Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
Tuberculosis (TB) remains one of the world’s leading infectious disease killers, yet millions of cases go undiagnosed or are detected too late. Barriers such as reliance on sputum samples, limited laboratory... Read morePathology
view channel
Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
Lung cancer is the leading cause of cancer death, killing more people in the United States than breast, prostate, and colon cancers combined. In lung adenocarcinoma (LUAD), tumors that invade nearby blood... Read more
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read moreTechnology
view channel
Online Tool Supports Family Screening for Inherited Cancer Risk
Genetic test results in oncology often have implications for relatives who may share inherited cancer risk. Many health systems lack structured processes to help patients alert family members, limiting... Read more
Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
Pneumonia is commonly confirmed with chest X-rays or laboratory assays that can take hours, delaying clinical decisions in acute and outpatient settings. Breath-based diagnostics promise faster answers... Read moreIndustry
view channel
Integrated DNA Technologies Expands into Clinical Diagnostics
Integrated DNA Technologies (IDT; Coralville, Iowa, USA) has announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx. This launch marks the company’s first in vitro diagnostic (IVD) offerings... Read more








